• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Iolcp Share Price

    Iol Chemicals And Pharmaceuticals Share PriceIOL Chemicals and Pharmaceuticals

    Small Cap 5.2k Result
    ₹454.7
    1.05 (0.23%)
    As on 04 December, 2023 | 01:44 BSE: 524164 NSE: IOLCPISIN: INE485C01011

    Iol Chemicals And Pharmaceuticals Performance

    Day Range

    • Low 453.65
    • High 460.00
    ₹ 454.7

    52 Week Range

    • Low 272.80
    • High 535.90
    ₹ 454.7
    • Open Price455.75
    • Previous Close453.65
    • Volume212197

    Start SIP in IOL Chemicals and Pharmaceuticals

    Start SIP

    Iol Chemicals And Pharmaceuticals Share Price

    • Over 1 Month 10.06%
    • Over 3 Month 5.43%
    • Over 6 Month 1.36%
    • Over 1 Year 31.3%

    Iol Chemicals And Pharmaceuticals Key Statistics

    P/E Ratio 15.5
    PEG Ratio 0.1
    Market Cap Cr 2,669
    Price to Book Ratio 1.8
    EPS 23.9
    Dividend 0.9
    Relative Strength Index 57.29
    Money Flow Index 73.72
    MACD Signal 0.14
    Average True Range 13.35

    Iol Chemicals And Pharmaceuticals Investment Rating

    • Master Rating:

    • Iol Chemicals & Pharms. has an operating revenue of Rs. 2,219.17 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 9% is okay, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 13% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 62 which is a FAIR score but needs to improve its earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 151 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    IOL Chemicals and Pharmaceuticals Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 545563587523541565572
    Operating Expenses Qtr Cr 481490491480510509529
    Operating Profit Qtr Cr 64739643325643
    Depreciation Qtr Cr 16141212111111
    Interest Qtr Cr 4455432
    Tax Qtr Cr 13152296129
    Net Profit Qtr Cr 38466524163528
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 2,2432,216
    Operating Expenses Annual Cr 1,9911,928
    Operating Profit Annual in Cr 227256
    Depreciation Cr 4643
    Interest Annual Cr 168
    Tax Annual Cr 5057
    Net Profit Annual Cr 140166
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 12391
    Cash from Investing Activity Annual Cr -119-120
    Cash from Financing Annual Activity Cr -4-2
    Net Cash Flow Annual Cr 0-31
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,5071,390
    Fixed Assets Annual Cr 841666
    Total Non Current Assets Annual Cr 1,102882
    Total Current Assets Annual Cr 9191,079
    Total Assets Annual Cr 2,0211,960
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 257237
    ROE Annual % 912
    ROCE Annual % 1317
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1113
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 545563587523541565572
    Operating Expenses Qtr Cr 481491492481510509527
    Operating Profit Qtr Cr 64739543325645
    Depreciation Qtr Cr 16141212111111
    Interest Qtr Cr 4455432
    Tax Qtr Cr 13152296129
    Net Profit Qtr Cr 38466524163530
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 2,2432,216
    Operating Expenses Annual Cr 1,9911,926
    Operating Profit Annual in Cr 226258
    Depreciation Cr 4643
    Interest Annual Cr 168
    Tax Annual Cr 5057
    Net Profit Annual Cr 139168
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 12293
    Cash from Investing Activity Annual Cr -120-120
    Cash from Financing Annual Activity Cr -4-2
    Net Cash Flow Annual Cr -2-29
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,5081,392
    Fixed Assets Annual Cr 841666
    Total Non Current Assets Annual Cr 1,102881
    Total Current Assets Annual Cr 9201,081
    Total Assets Annual Cr 2,0221,962
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 257237
    ROE Annual % 912
    ROCE Annual % 1317
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1113
    Invest in Iol Chemicals And Pharmaceuticals

    Iol Chemicals And Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹454.7
    1.05 (0.23%)
    pointer
    • Bullish Moving Average
    • ___
    • 15
    • Bearish Moving Average
    • ___
    • 1
    • 20 Day
    • ₹443.64
    • 50 Day
    • ₹441.39
    • 100 Day
    • ₹431.64
    • 200 Day
    • ₹414.10
    • 20 Day
    • ₹439.56
    • 50 Day
    • ₹449.40
    • 100 Day
    • ₹426.79
    • 200 Day
    • ₹399.51

    Iol Chemicals And Pharmaceuticals Resistance and Support

    PIVOT
    ₹456.12
    Resistance
    First Resistance 458.58
    Second Resistance 462.47
    Third Resistance 464.93
    RSI 57.29
    MFI 73.72
    MACD Single Line 0.14
    MACD 3.65
    Support
    First Resistance 452.23
    Second Resistance 449.77
    Third Resistance 445.88

    Iol Chemicals And Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 230,946 11,394,876 49.34
    Week 330,928 15,166,419 45.83
    1 Month 345,916 13,086,004 37.83
    6 Month 619,857 20,399,494 32.91

    Iol Chemicals And Pharmaceuticals Result Highlights

    IOL Chemicals and Pharmaceuticals Synopsis

    NSE-Chemicals-Specialty

    Iol Chemicals And Ph is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2217.11 Cr. and Equity Capital is Rs. 58.71 Cr. for the Year ended 31/03/2023. IOL Chemicals and Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 29/09/1986 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24116PB1986PLC007030 and registration number is 007030.
    Market Cap 2,669
    Sales 2,219
    Shares in Float 3.05
    No of funds 52
    Yield 0.88
    Book Value 1.77
    U/D Vol ratio 0.8
    LTDebt / Equity
    Alpha 0.13
    Beta 0.72

    IOL Chemicals and Pharmaceuticals

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 48.19%48.19%48.19%43.69%
    Mutual Funds 0.05%0.02%0.02%0.02%
    Foreign Portfolio Investors 2.33%3.54%2.43%2.37%
    Individual Investors 30.28%29.28%30.49%30.91%
    Others 19.15%18.97%18.87%23.01%

    IOL Chemicals and Pharmaceuticals Management

    Name Designation
    Mr. Rajender Mohan Malla Chairman & Ind.Director
    Mr. Varinder Gupta Managing Director
    Mr. Vikas Gupta Joint Managing Director
    Mr. Kushal Kumar Rana Director - Works
    Dr.(Mrs.) Sandhya Mehta Independent Director
    Mr. Harpal Singh Independent Director
    Mr. Sharad Tyagi Independent Director
    Mr. Abhiraj Gupta Executive Director

    Iol Chemicals And Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Iol Chemicals And Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2023-11-08 Quarterly Results
    2023-08-09 Quarterly Results
    2023-04-28 Audited Results
    2023-02-07 Audited Results & Interim Dividend
    2022-11-14 Quarterly Results
    Date Purpose Remarks
    2023-02-17 INTERIM Rs.4.00 per share(40%)Interim Dividend
    2022-02-16 INTERIM Rs.4.00 per share(40%)Interim Dividend

    IOL Chemicals and Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
    Groww Nifty Total Market Index Fund Regular Growth 32
    Motilal Oswal S&P BSE Healthcare ETF 8

    IOL Chemicals and Pharmaceuticals FAQs

    What is Share Price of IOL Chemicals and Pharmaceuticals ?

    IOL Chemicals and Pharmaceuticals share price is ₹454 As on 04 December, 2023 | 01:30

    What is the Market Cap of IOL Chemicals and Pharmaceuticals ?

    The Market Cap of IOL Chemicals and Pharmaceuticals is ₹2669.3 Cr As on 04 December, 2023 | 01:30

    What is the P/E ratio of IOL Chemicals and Pharmaceuticals ?

    The P/E ratio of IOL Chemicals and Pharmaceuticals is 15.5 As on 04 December, 2023 | 01:30

    What is the PB ratio of IOL Chemicals and Pharmaceuticals ?

    The PB ratio of IOL Chemicals and Pharmaceuticals is 1.8 As on 04 December, 2023 | 01:30

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.